Here’s a great article outlining the IDSA’s efforts to work with the FDA to expand the definition of “orphan” drug to include antibiotics. I think we can all agree that these agents have been treated like unwanted foster stepchildren by pharma. Perhaps this can be the “game changer”?! http://www.fiercebiotech.com/story/fda-nudged-treat-antibiotics-rare-disease-drugs/2012-03-09
View post:
Expanding the Orphanage for Orphan Drugs
Related posts:
- A game changer for wound care: National Health Service recommends use of wound "litmus test"
- Bugs and Drugs 2011 (Slide Show)
- Aubrey de Grey, SENS, anti-aging drugs, and clinical trials. – Slate Magazine
- A Wirelessly Controlled Pharmacy Dispenses Drugs From Within Your Abdomen | Popular Science
- Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs; a possible ‘anti-proarrhythmic’ role for amlodipine
- Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against…
- Read this study: Diabetic Foot Infections + Nutritional Supplementation = Less Antibiotics
- Foot bones allow researchers to determine sex of skeletal remains
- The Artificial Pancreas is here. Studies enrolling.
- Medical revolution via Google Glasses?
